Outlook Therapeutics
OTLK
#8491
Rank
ยฃ0.10 B
Marketcap
ยฃ4.35
Share price
-7.55%
Change (1 day)
-39.28%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -ยฃ74.85 Million

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ40.67 Million, an increase over its 2022 earnings that were of -ยฃ55.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ74.85 Million84.05%
2023 -ยฃ40.67 Million-26.7%
2022 -ยฃ55.48 Million32.13%
2021 -ยฃ41.99 Million46.21%
2020 -ยฃ28.72 Million-18.82%
2019 -ยฃ35.38 Million16.62%
2018 -ยฃ30.34 Million57.88%
2017 -ยฃ19.22 Million-56.17%
2016 -ยฃ43.84 Million-9.26%
2015 -ยฃ48.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-ยฃ90.39 Million 21.71% Jersey
-ยฃ0.22 Billion 190.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ11.05 Million-85.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ57.7 Million-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK